Literature DB >> 26754469

Prediction of later clinical course by a specific glucose metabolic pattern in non-demented patients with probable REM sleep behavior disorder admitted to a memory clinic: A case study.

Kazumi Ota1, Hiroshige Fujishiro1, Koji Kasanuki2, Daizo Kondo1, Yuhei Chiba1, Norio Murayama1, Heii Arai3, Kiyoshi Sato1, Eizo Iseki4.   

Abstract

The present study is a follow-up study of 11 non-demented patients with probable rapid eye movement (REM) sleep behavior disorder (RBD) at our memory clinic. During the follow-up period (mean±SD of 46.7±6.4 months), all 11 patients exhibited cognitive decline: four (Group A) exhibited core clinical features of dementia with Lewy bodies (DLB), along with severe cognitive decline, and were subsequently diagnosed as having probable DLB; four (Group B) did not exhibit core clinical features of DLB; and the remaining three (Group C) were diagnosed as having Parkinson's disease with dementia (PDD). Positron emission tomography with fluorodeoxyglucose-F18 at baseline revealed that Groups A and B exhibited glucose hypometabolism in the occipital lobe, especially in the primary visual cortex, and Group A tended to present hypometabolism in the parieto-temporal area as well. Group C tended to present hypometabolism in the medial prefrontal area and anterior cingulate gyrus. Neuropsychological examinations indicated poor performance in verbal memory and visuoperception in all groups. This case study suggests that patterns of hypometabolism and neuropsychological examinations at baseline may be indicators of the later clinical course of probable RBD patients.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Dementia with lewy bodies; Early diagnosis; FDG-PET; Mild cognitive impairment; REM sleep behavior disorder; Visuoperception

Mesh:

Substances:

Year:  2015        PMID: 26754469     DOI: 10.1016/j.pscychresns.2015.12.004

Source DB:  PubMed          Journal:  Psychiatry Res Neuroimaging        ISSN: 0925-4927            Impact factor:   2.376


  6 in total

1.  Brain Metabolism Related to Mild Cognitive Impairment and Phenoconversion in Patients With Isolated REM Sleep Behavior Disorder.

Authors:  Eun Jin Yoon; Jee-Young Lee; Heejung Kim; Dallah Yoo; Jung Hwan Shin; Hyunwoo Nam; Beomseok Jeon; Yu Kyeong Kim
Journal:  Neurology       Date:  2022-04-18       Impact factor: 11.800

2.  Comparative Study on Topological Properties of the Whole-Brain Functional Connectome in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease Without RBD.

Authors:  Shuai Chen; Sheng-Hui Wang; Ying-Ying Bai; Jie-Wen Zhang; Hong-Ju Zhang
Journal:  Front Aging Neurosci       Date:  2022-04-11       Impact factor: 5.702

3.  Characterizing the heterogeneous metabolic progression in idiopathic REM sleep behavior disorder.

Authors:  Xianhua Han; Ping Wu; Ian Alberts; Hucheng Zhou; Huan Yu; Panagiotis Bargiotas; Igor Yakushev; Jian Wang; Guenter Höglinger; Stefan Förster; Claudio Bassetti; Wolfgang Oertel; Markus Schwaiger; Sung-Cheng Huang; Paul Cumming; Axel Rominger; Jiehui Jiang; Chuantao Zuo; Kuangyu Shi
Journal:  Neuroimage Clin       Date:  2020-05-26       Impact factor: 4.881

Review 4.  Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson's Disease.

Authors:  Ane Murueta-Goyena; Ane Andikoetxea; Juan Carlos Gómez-Esteban; Iñigo Gabilondo
Journal:  Front Pharmacol       Date:  2019-10-30       Impact factor: 5.810

Review 5.  Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies.

Authors:  Maja Trošt; Matej Perovnik; Zvezdan Pirtošek
Journal:  Front Neurol       Date:  2019-11-14       Impact factor: 4.003

6.  Assessing gray matter volume in patients with idiopathic rapid eye movement sleep behavior disorder.

Authors:  Xian-Hua Han; Xiu-Ming Li; Wei-Jun Tang; Huan Yu; Ping Wu; Jing-Jie Ge; Jian Wang; Chuan-Tao Zuo; Kuang-Yu Shi
Journal:  Neural Regen Res       Date:  2019-05       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.